Rahul Deo, MD, PhD


Dr. Rahul Deo is a cardiologist in the Cardiovascular Care and Prevention Center at UCSF Medical Center who is particularly interested in patients and their families with inherited cardiovascular disease, particularly cardiomyopathies or diseases of the heart muscle.

Deo, a native of Canada, earned a medical degree at Cornell University Medical College and a doctorate in molecular biophysics at Rockefeller University, both in New York, as part of the Tri-Institutional M.D.-Ph.D. Program. He completed an internship and residency in internal medicine at Brigham and Women's Hospital and a cardiology fellowship at the Massachusetts General Hospital in Boston. He then conducted postdoctoral research in human genetics and computational biology at Harvard Medical School. Deo's research interests focus on large-scale genetic and genomic data to develop personalized diagnosis and therapy in cardiovascular medicine. He is an associate professor in residence in medicine at UCSF.


Cardiovascular Care and Prevention Center at Mission Bay
535 Mission Bay Blvd. South
San Francisco, CA 94158
Phone: (415) 353-2873
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Cardiovascular Disease, American Board of Internal Medicine

More about Rahul Deo


Weill Cornell Medical University School of Medicine 2003


Brigham & Womens Hospital 2006


Massachusetts General Hospital 2011

Selected Research and Publications

  1. Odegaard JI, Lee MW, Sogawa Y, Bertholet AM, Locksley RM, Weinberg DE, Kirichok Y, Deo RC, Chawla A. Perinatal Licensing of Thermogenesis by IL-33 and ST2. Cell. 2017 Dec 14; 171(7):1707.
  2. Corbit KC, Camporez JPG, Edmunds LR, Tran JL, Vera NB, Erion DM, Deo RC, Perry RJ, Shulman GI, Jurczak MJ, Weiss EJ. Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling. Diabetes. 2018 Feb; 67(2):208-221.
  3. Friesen M, Camahort R, Lee YK, Xia F, Gerszten RE, Rhee EP, Deo RC, Cowan CA. Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease. Stem Cell Reports. 2017 05 09; 8(5):1164-1173.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.